Thymoma: Current medical and surgical management

Research output: Contribution to journalReview article

15 Citations (Scopus)

Abstract

Thymoma is a rare neoplasm usually with an indolent growth pattern; however, local invasion and/or dissemination may occur. Surgery has been the standard of care for early stage disease with good to excellent cure rates anticipated. This neoplasm has been found to be relatively sensitive to cisplatinum-based chemotherapy as compared with most other epithelial tumors. Aggressive multimodality therapy therefore can result in long-term disease-free survival for patients presenting with locally advanced or even disseminated disease. This chapter outlines the current medical and surgical treatment options for thymoma.

Original languageEnglish (US)
Pages (from-to)63-73
Number of pages11
JournalSeminars in neurology
Volume24
Issue number1
DOIs
StatePublished - Mar 1 2004

Fingerprint

Thymoma
Neoplasms
Standard of Care
Disease-Free Survival
Drug Therapy
Therapeutics
Growth

Keywords

  • Chemotherapy
  • Myasthenia gravis
  • Surgery
  • Thymoma

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

Thymoma : Current medical and surgical management. / Kesler, Kenneth A.; Wright, Cameron D.; Loehrer, Patrick J.

In: Seminars in neurology, Vol. 24, No. 1, 01.03.2004, p. 63-73.

Research output: Contribution to journalReview article

@article{6db3fb735a564574ab3b0f87a95aec65,
title = "Thymoma: Current medical and surgical management",
abstract = "Thymoma is a rare neoplasm usually with an indolent growth pattern; however, local invasion and/or dissemination may occur. Surgery has been the standard of care for early stage disease with good to excellent cure rates anticipated. This neoplasm has been found to be relatively sensitive to cisplatinum-based chemotherapy as compared with most other epithelial tumors. Aggressive multimodality therapy therefore can result in long-term disease-free survival for patients presenting with locally advanced or even disseminated disease. This chapter outlines the current medical and surgical treatment options for thymoma.",
keywords = "Chemotherapy, Myasthenia gravis, Surgery, Thymoma",
author = "Kesler, {Kenneth A.} and Wright, {Cameron D.} and Loehrer, {Patrick J.}",
year = "2004",
month = "3",
day = "1",
doi = "10.1055/s-2004-829588",
language = "English (US)",
volume = "24",
pages = "63--73",
journal = "Seminars in Neurology",
issn = "0271-8235",
publisher = "Thieme Medical Publishers",
number = "1",

}

TY - JOUR

T1 - Thymoma

T2 - Current medical and surgical management

AU - Kesler, Kenneth A.

AU - Wright, Cameron D.

AU - Loehrer, Patrick J.

PY - 2004/3/1

Y1 - 2004/3/1

N2 - Thymoma is a rare neoplasm usually with an indolent growth pattern; however, local invasion and/or dissemination may occur. Surgery has been the standard of care for early stage disease with good to excellent cure rates anticipated. This neoplasm has been found to be relatively sensitive to cisplatinum-based chemotherapy as compared with most other epithelial tumors. Aggressive multimodality therapy therefore can result in long-term disease-free survival for patients presenting with locally advanced or even disseminated disease. This chapter outlines the current medical and surgical treatment options for thymoma.

AB - Thymoma is a rare neoplasm usually with an indolent growth pattern; however, local invasion and/or dissemination may occur. Surgery has been the standard of care for early stage disease with good to excellent cure rates anticipated. This neoplasm has been found to be relatively sensitive to cisplatinum-based chemotherapy as compared with most other epithelial tumors. Aggressive multimodality therapy therefore can result in long-term disease-free survival for patients presenting with locally advanced or even disseminated disease. This chapter outlines the current medical and surgical treatment options for thymoma.

KW - Chemotherapy

KW - Myasthenia gravis

KW - Surgery

KW - Thymoma

UR - http://www.scopus.com/inward/record.url?scp=3042588701&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3042588701&partnerID=8YFLogxK

U2 - 10.1055/s-2004-829588

DO - 10.1055/s-2004-829588

M3 - Review article

C2 - 15229793

AN - SCOPUS:3042588701

VL - 24

SP - 63

EP - 73

JO - Seminars in Neurology

JF - Seminars in Neurology

SN - 0271-8235

IS - 1

ER -